Acasti Pharma Reports Results of Annual and Special Meeting
6/28/2013 8:57:48 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LAVAL, Quebec, June 28, 2013 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti" or the "Corporation") (Nasdaq:ACST) (TSX-V:APO), a Neptune Technologies & Bioressources Inc.'s ("Neptune") subsidiary, announces that at its Annual and Special Meeting (the "Meeting"), held on June 27, 2013, the Corporation's shareholders voted in favour of all items put forth at the Meeting and outlined in the Corporation's management proxy circular dated May 22, 2013 (the "Circular") available on SEDAR at www.sedar.com.
Help employers find you! Check out all the jobs and post your resume.